PTJ
OPRX icon

Paul Tudor Jones’s OptimizeRx OPRX Stock Holding History

Paul Tudor Jones’s Portfolio OPRX Stock Details OPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-30,519
Closed -$305K – 2998
2024
Q2 		$305K Sell
30,519
-22,463
-42% -$247K ﹤0.01% 2007
2024
Q1 		$644K Buy
52,982
+38,631
+269% +$560K ﹤0.01% 1536
2023
Q4 		$205K Sell
14,351
-10,555
-42% -$101K ﹤0.01% 2196
2023
Q3 		$194K Sell
24,906
-18,346
-42% -$200K ﹤0.01% 2100
2023
Q2 		$618K Buy
43,252
+605
+1% +$8.62K 0.01% 1588
2023
Q1 		$624K Buy
42,647
+28,108
+193% +$470K 0.01% 1487
2022
Q4 		$244K Sell
14,539
-19,340
-57% -$334K ﹤0.01% 2030
2022
Q3 		$502K Buy
+33,879
New +$670K 0.01% 1392
2021
Q3 		– Sell
-20,532
Closed -$1.27M – 2708
2021
Q2 		$1.27M Buy
20,532
+16,320
+387% +$831K 0.02% 755
2021
Q1 		$205K Buy
+4,212
New +$203K ﹤0.01% 1424

Other funds holding OPRX

FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIC
AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return
SM
Samjo Management New York $293M AUM 57.03% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $5.65B AUM 61.31% 1-Year Est. Return

Paul Tudor Jones's OPRX Position: Q3 2024 in Review

Paul Tudor Jones sold out of OptimizeRx (OPRX) in Q3 2024, closing a stake of 30,519 shares — an estimated $305K sold.

Paul Tudor Jones first reported a position in OPRX in Q1 2021 and held it in 10 quarters. The position peaked at $1.27M in Q2 2021. 85 funds tracked by Wall St. Rank hold OPRX as of Q3 2024.

  • Paul Tudor Jones reported no remaining OptimizeRx position as of Q3 2024 after selling out during the quarter.
  • Paul Tudor Jones sold 30,519 OptimizeRx shares in Q3 2024, an estimated $305K.
  • Paul Tudor Jones first reported a position in OptimizeRx in Q1 2021 and held it in 10 quarters.
  • Paul Tudor Jones's OptimizeRx position peaked at $1.27M in Q2 2021.
  • 85 funds tracked by Wall St. Rank held OptimizeRx as of Q3 2024.

Based on Tudor Investment Corp's 13F filing for Q3 2024, filed 14 Nov 2024.